352 related articles for article (PubMed ID: 36631153)
1. Long covid outcomes at one year after mild SARS-CoV-2 infection: nationwide cohort study.
Mizrahi B; Sudry T; Flaks-Manov N; Yehezkelli Y; Kalkstein N; Akiva P; Ekka-Zohar A; Ben David SS; Lerner U; Bivas-Benita M; Greenfeld S
BMJ; 2023 Jan; 380():e072529. PubMed ID: 36631153
[TBL] [Abstract][Full Text] [Related]
2. Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: an analysis of 2-year retrospective cohort studies including 1 284 437 patients.
Taquet M; Sillett R; Zhu L; Mendel J; Camplisson I; Dercon Q; Harrison PJ
Lancet Psychiatry; 2022 Oct; 9(10):815-827. PubMed ID: 35987197
[TBL] [Abstract][Full Text] [Related]
3. Six-month sequelae of post-vaccination SARS-CoV-2 infection: A retrospective cohort study of 10,024 breakthrough infections.
Taquet M; Dercon Q; Harrison PJ
Brain Behav Immun; 2022 Jul; 103():154-162. PubMed ID: 35447302
[TBL] [Abstract][Full Text] [Related]
4. Long COVID symptoms and duration in SARS-CoV-2 positive children - a nationwide cohort study.
Borch L; Holm M; Knudsen M; Ellermann-Eriksen S; Hagstroem S
Eur J Pediatr; 2022 Apr; 181(4):1597-1607. PubMed ID: 35000003
[TBL] [Abstract][Full Text] [Related]
5. Risk of persistent and new clinical sequelae among adults aged 65 years and older during the post-acute phase of SARS-CoV-2 infection: retrospective cohort study.
Cohen K; Ren S; Heath K; Dasmariñas MC; Jubilo KG; Guo Y; Lipsitch M; Daugherty SE
BMJ; 2022 Feb; 376():e068414. PubMed ID: 35140117
[TBL] [Abstract][Full Text] [Related]
6. Sex-Related Differences in Long-COVID-19 Syndrome.
Pelà G; Goldoni M; Solinas E; Cavalli C; Tagliaferri S; Ranzieri S; Frizzelli A; Marchi L; Mori PA; Majori M; Aiello M; Corradi M; Chetta A
J Womens Health (Larchmt); 2022 May; 31(5):620-630. PubMed ID: 35333613
[No Abstract] [Full Text] [Related]
7. Long-COVID in patients with a history of mild or asymptomatic SARS-CoV-2 infection: a Nationwide Cohort Study.
Adler L; Gazit S; Pinto Y; Perez G; Mizrahi Reuveni M; Yehoshua I; Hoffman R; Azuri J; Patalon T
Scand J Prim Health Care; 2022 Sep; 40(3):342-349. PubMed ID: 36314555
[TBL] [Abstract][Full Text] [Related]
8. Risk of clinical sequelae after the acute phase of SARS-CoV-2 infection: retrospective cohort study.
Daugherty SE; Guo Y; Heath K; Dasmariñas MC; Jubilo KG; Samranvedhya J; Lipsitch M; Cohen K
BMJ; 2021 May; 373():n1098. PubMed ID: 34011492
[TBL] [Abstract][Full Text] [Related]
9. Risks and burdens of incident dyslipidaemia in long COVID: a cohort study.
Xu E; Xie Y; Al-Aly Z
Lancet Diabetes Endocrinol; 2023 Feb; 11(2):120-128. PubMed ID: 36623520
[TBL] [Abstract][Full Text] [Related]
10. Youth Mental Health Outcomes up to Two Years After SARS-CoV-2 Infection Long-COVID or Long-Pandemic Syndrome: A Retrospective Cohort Study.
Bilu Y; Flaks-Manov N; Goldshtein I; Bivas-Benita M; Akiva P; Bodenheimer G; Greenfeld S
J Adolesc Health; 2023 Oct; 73(4):701-706. PubMed ID: 37389526
[TBL] [Abstract][Full Text] [Related]
11. Risk of SARS-CoV-2 reinfection and COVID-19 hospitalisation in individuals with natural and hybrid immunity: a retrospective, total population cohort study in Sweden.
Nordström P; Ballin M; Nordström A
Lancet Infect Dis; 2022 Jun; 22(6):781-790. PubMed ID: 35366962
[TBL] [Abstract][Full Text] [Related]
12. Risk of breakthrough SARS-CoV-2 infection and clinical outcomes among vaccinated patients with type 2 diabetes.
Bea S; Choi A; Kim JH; Cho YM; Choi WS; Jung J; Shin JY
Diabetes Obes Metab; 2023 Sep; 25(9):2734-2742. PubMed ID: 37312652
[TBL] [Abstract][Full Text] [Related]
13. Transmission and Infectious SARS-CoV-2 Shedding Kinetics in Vaccinated and Unvaccinated Individuals.
Jung J; Kim JY; Park H; Park S; Lim JS; Lim SY; Bae S; Lim YJ; Kim EO; Kim J; Park MS; Kim SH
JAMA Netw Open; 2022 May; 5(5):e2213606. PubMed ID: 35608859
[TBL] [Abstract][Full Text] [Related]
14. Potential reduction of post-acute sequelae of SARS-CoV-2 symptoms via vaccination.
Vanichkachorn G; Gilman E; Ganesh R; Mueller M; Swift M; Breeher L; Murad MH
J Investig Med; 2023 Dec; 71(8):889-895. PubMed ID: 37497990
[TBL] [Abstract][Full Text] [Related]
15. Post-acute symptoms 3-15 months after COVID-19 among unvaccinated and vaccinated individuals with a breakthrough infection.
Brunvoll SH; Nygaard AB; Fagerland MW; Holland P; Ellingjord-Dale M; Dahl JA; Søraas A
Int J Infect Dis; 2023 Jan; 126():10-13. PubMed ID: 36375693
[TBL] [Abstract][Full Text] [Related]
16. Symptoms and risk factors for long COVID in non-hospitalized adults.
Subramanian A; Nirantharakumar K; Hughes S; Myles P; Williams T; Gokhale KM; Taverner T; Chandan JS; Brown K; Simms-Williams N; Shah AD; Singh M; Kidy F; Okoth K; Hotham R; Bashir N; Cockburn N; Lee SI; Turner GM; Gkoutos GV; Aiyegbusi OL; McMullan C; Denniston AK; Sapey E; Lord JM; Wraith DC; Leggett E; Iles C; Marshall T; Price MJ; Marwaha S; Davies EH; Jackson LJ; Matthews KL; Camaradou J; Calvert M; Haroon S
Nat Med; 2022 Aug; 28(8):1706-1714. PubMed ID: 35879616
[TBL] [Abstract][Full Text] [Related]
17. Health Care Utilization in the 6 Months Following SARS-CoV-2 Infection.
Tartof SY; Malden DE; Liu IA; Sy LS; Lewin BJ; Williams JTB; Hambidge SJ; Alpern JD; Daley MF; Nelson JC; McClure D; Zerbo O; Henninger ML; Fuller C; Weintraub E; Saydah S; Qian L
JAMA Netw Open; 2022 Aug; 5(8):e2225657. PubMed ID: 35960522
[TBL] [Abstract][Full Text] [Related]
18. Long COVID after breakthrough SARS-CoV-2 infection.
Al-Aly Z; Bowe B; Xie Y
Nat Med; 2022 Jul; 28(7):1461-1467. PubMed ID: 35614233
[TBL] [Abstract][Full Text] [Related]
19. Breakthrough SARS-CoV-2 Infections, Hospitalizations, and Mortality in Vaccinated Patients With Cancer in the US Between December 2020 and November 2021.
Wang W; Kaelber DC; Xu R; Berger NA
JAMA Oncol; 2022 Jul; 8(7):1027-1034. PubMed ID: 35394485
[TBL] [Abstract][Full Text] [Related]
20. Impact of vaccination on postacute sequelae of SARS CoV-2 infection in patients with rheumatic diseases.
Patel NJ; Cook C; Vanni K; Fu X; Wang X; Kawano Y; Qian G; Hang B; Srivatsan S; Banasiak EP; Kowalski E; Bade K; Zhang Y; Sparks JA; Wallace ZS
Ann Rheum Dis; 2023 Apr; 82(4):565-573. PubMed ID: 36442978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
